{"title":"Effect of diclofenac sodium on osteoclast formation","authors":"M. Nobukawa, S. Yamada, H. Amano","doi":"10.11263/JSOTP1982.20.196","DOIUrl":"https://doi.org/10.11263/JSOTP1982.20.196","url":null,"abstract":"Nonsteroidal anti-inflammatory drugs (NSAIDs) are one of the most commonly used classes of medications worldwide. Diclofenac sodium is a kind of NSAIDs advocated for use in dental medicine. It is also well known to prevent osteoporosis in postmenopausal females. The purpose of the present study was to investigate the possible inhibitory effect on osteoclastogenesis in the presence of diclofenac sodium. Nonadherent Sephadex G10-passed bone marrow cells were cultured in a-MEM containing the final concentration of 15% FBS, 60ng/mL RANKL, 20ng/mL CSF-1 for 6 days. Treatment with diclofenac sodium blocked osteoclastogenesis in vitro dose-dependently. The results suggested that diclofenac sodium may act on the precursor of osteoclast directly to prevent osteoporosis.","PeriodicalId":19590,"journal":{"name":"Oral Therapeutics and Pharmacology","volume":"20 1","pages":"196-198"},"PeriodicalIF":0.0,"publicationDate":"2001-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63816843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yoshio Saito, Miyuki Ikeda, Hidemi Tanaka, J. Iijima, K. Sakata
{"title":"A Literatue Study of Oral Therapeutics and Pharmacology","authors":"Yoshio Saito, Miyuki Ikeda, Hidemi Tanaka, J. Iijima, K. Sakata","doi":"10.11263/JSOTP1982.20.110","DOIUrl":"https://doi.org/10.11263/JSOTP1982.20.110","url":null,"abstract":"","PeriodicalId":19590,"journal":{"name":"Oral Therapeutics and Pharmacology","volume":"20 1","pages":"110-116"},"PeriodicalIF":0.0,"publicationDate":"2001-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63817075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Otsuru, A. Kaneko, Yusuke Mori, N. Nakatogawa, J. Sasaki, N. Yamane, Hiroshi Takanohashi, I. Kobayashi
{"title":"Pharmacokinetic study of one dose of 750mg of Amoxicillin","authors":"M. Otsuru, A. Kaneko, Yusuke Mori, N. Nakatogawa, J. Sasaki, N. Yamane, Hiroshi Takanohashi, I. Kobayashi","doi":"10.11263/JSOTP1982.20.78","DOIUrl":"https://doi.org/10.11263/JSOTP1982.20.78","url":null,"abstract":"We studied the prevention of bacterial endocarditis, lowering the incidence of transient bacteremia by administering antimicrobial agents prior to tooth extractions. In Japan, the regimen recommends oral administration of amoxicillin (AMPC) to moderate-risk patients. In the present study, one dose of 750mg of amoxicillin was administered orally to four healthy volunteers. Afterward, blood concentrations of the drugs were measured by bioassay. A pharamacokinetic study was performed using one compartment model.","PeriodicalId":19590,"journal":{"name":"Oral Therapeutics and Pharmacology","volume":"20 1","pages":"78-81"},"PeriodicalIF":0.0,"publicationDate":"2001-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63817551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"In vitroantimicrobial activity of ampicillin, panipenem, and ofloxacin against oral Streptococci adherent to solid phase","authors":"Ayumi Yoshioka, T. Yoshii, I. Takenono, T. Komori","doi":"10.11263/JSOTP1982.20.82","DOIUrl":"https://doi.org/10.11263/JSOTP1982.20.82","url":null,"abstract":"We investigated the antimicrobial activity of ampicillin, panipenem, and ofloxacin against oral Streptococci, which were isolated from odontogenic infections, adherent to solid phase. The minimum inhibitory concentration (MICAD) and minimum bactericidal concentration (MBCAD) for 10 oral Streptococci (S. mitis, 2 strains ; S. sanguis, 5 ; S. salivarius, 1 ; S. mutans, 1 ; S. oxalis, 1) that were adhered to the bottom of multi-well plastic tissue culture plates, were determined. The results were as follows : MICAD, 0.025*12.5li g/mL, and MBCAD, 200•`>400ƒÊg/mL, for ampicillin ; MICAD, <0.025-0.025ƒÊg/mL, and MBCAD, 12.5 •`> 400ƒÊg/mL, for panipenem ; and MICAD, <0.025-1.56ƒÊg/mL, and MBCAD, 50•`> 400ƒÊg/mL, for ofloxacin. From the results above, it is clear that oral Streptococci can show a much higher MBCAD than MICAD when adhering to solid phase, although there are some differences according to the antibiotics and strains studied.","PeriodicalId":19590,"journal":{"name":"Oral Therapeutics and Pharmacology","volume":"20 1","pages":"82-85"},"PeriodicalIF":0.0,"publicationDate":"2001-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63817664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The choice of antimicrobial agents based on prompt Gram's staining","authors":"J. Sasaki, Yusuke Mori, Hiroshi Takanohashi","doi":"10.11263/JSOTP1982.20.92","DOIUrl":"https://doi.org/10.11263/JSOTP1982.20.92","url":null,"abstract":"","PeriodicalId":19590,"journal":{"name":"Oral Therapeutics and Pharmacology","volume":"122 1","pages":"92-95"},"PeriodicalIF":0.0,"publicationDate":"2001-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63817371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
H. Ishii, Y. Nakagawa, Takayuki Shiga, T. Shimizu, M. Sakai, K. Asada, K. Ishibashi
{"title":"Effects of Cevimeline hydrochloride on salivary secretion in streptozotocin-induced diabetic Balb/ cA mice","authors":"H. Ishii, Y. Nakagawa, Takayuki Shiga, T. Shimizu, M. Sakai, K. Asada, K. Ishibashi","doi":"10.11263/JSOTP1982.20.86","DOIUrl":"https://doi.org/10.11263/JSOTP1982.20.86","url":null,"abstract":"","PeriodicalId":19590,"journal":{"name":"Oral Therapeutics and Pharmacology","volume":"20 1","pages":"86-91"},"PeriodicalIF":0.0,"publicationDate":"2001-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63817235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Y. Nakagawa, H. Ishii, Takashi Saito, Takahiro Wakui, Taketomo Sato, Katsunori Ishibashii, M. Humphreys-Beher
{"title":"Effects of chronic administration of pilocarpine on saliva secretion in streptozotocin-induced diabetic mice","authors":"Y. Nakagawa, H. Ishii, Takashi Saito, Takahiro Wakui, Taketomo Sato, Katsunori Ishibashii, M. Humphreys-Beher","doi":"10.11263/JSOTP1982.20.96","DOIUrl":"https://doi.org/10.11263/JSOTP1982.20.96","url":null,"abstract":"Pilocarpine is a parasympathomimetic agonist and one of the most extensively studied salivary stimulants. Salivary hypofunction patients require long-term administration of secretagogues, but little is known about the effects of chronic administration of pilocarpine on saliva secretion. Hence, in the present study, we evaluated the effects of chronic administration of pilocarpine on saliva secretion in streptozotocin (STZ)-induced diabetic mice. Four weeks after induction of diabetes, saliva flow rate, protein concentration, and amylase activity were measured, by collecting saliva from the oral cavity over 30 min following an injection of pilocarpine. The effects of 7 days of pilocarpine administration were compared with the effects of a single injection. Saliva flow following a single intraperitoneal pilocarpine injection was significantly lower in the STZ diabetic mice than the control mice (buffer injection). With chronic administration of pilocarpine, the rate of saliva release increased significantly in the first 10-min period following injection, both in the diabetic and control mice, compared with the single pilocarpine injection results. The total amylase secretion over 30 min induced by a single injection of pilocarpine was not reduced in diabetic mice, despite a decrease in total salivary protein secretion. After chronic administration of pilocarpine, protein secretion increased both in the diabetic and control mice, compared with single injection levels. Chronic administration tended to increase total amylase activity in the control mice, but not the diabetic mice. The present study has clarified the effects of chronic administration of pilocarpine, and suggests that pilocarpine may be beneficial for patients with salivary gland dysfunction.","PeriodicalId":19590,"journal":{"name":"Oral Therapeutics and Pharmacology","volume":"20 1","pages":"96-103"},"PeriodicalIF":0.0,"publicationDate":"2001-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63817739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Koichi Ito, N. Yoshinuma, N. Sugano, Shuichi Sato, T. Nishida, M. Matsue, H. Masunaga, K. Hozumi, Fumihiko Ymanouchi, Akihiko Gunji, A. Fujii
{"title":"A Clinical Trial of SBJ-PRO2 for Dental Plaque Removal","authors":"Koichi Ito, N. Yoshinuma, N. Sugano, Shuichi Sato, T. Nishida, M. Matsue, H. Masunaga, K. Hozumi, Fumihiko Ymanouchi, Akihiko Gunji, A. Fujii","doi":"10.11263/JSOTP1982.20.23","DOIUrl":"https://doi.org/10.11263/JSOTP1982.20.23","url":null,"abstract":"","PeriodicalId":19590,"journal":{"name":"Oral Therapeutics and Pharmacology","volume":"20 1","pages":"23-31"},"PeriodicalIF":0.0,"publicationDate":"2001-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63817033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A pharmacological and immunopharmacological study on allergic reaction induced by rosin","authors":"Takafumi Katuta, T. Ohsumi","doi":"10.11263/JSOTP1982.20.11","DOIUrl":"https://doi.org/10.11263/JSOTP1982.20.11","url":null,"abstract":"Dental drugs and dental materials induce several allergic reactions, but our knowledge about the causal substances and the mechanism of allergic reactions is still limited. In this study, we conducted pharmacological and immunopharmacological examinations of rosin, which is included in many preparations, such as pulp capping agents and root canal filling agents. First, we used the adjuvant and patch test in guinea pigs. Twenty-four hours after challenge, erythema was noted in all 3 animals to which we applied 25, 12.5, and 5 % rosin and edema was also noted in one of the animals to which we applied 25% rosin, second, to examine places where rosin causes type IV allergic reactions, the ear swelling test in mice was conducted. At 5 % rosin, the difference was significant ; at 25% rosin, the swelling rate was as high as 55%. From the above two examinations, the results indicated that contact dermatitis, which is type N allergy, may be induced by dental drugs and dental materials containing rosin, and the induction of allergy depended on the concentration of rosin. Third, the kinetics of immunocytes was examined in mice to which we applied 25% rosin in the ear swelling test. The distribution of immunocytes in the ears and lymph nodes was immunohistochemically examined by the indirect enzyme-labeled antibody method. Thy-1.2, CD4, interleukin-2 receptor (IL-2R), IL-4R and CD8-positive cells were detected by light microscopy. The number of IL-4R and CD8-positive cells was increased in the effector phase. It is suggested that Th-2 rather than Th-1 was involved in allergy induced by rosin, and clarified that CD8 positive cells were involved.","PeriodicalId":19590,"journal":{"name":"Oral Therapeutics and Pharmacology","volume":"20 1","pages":"11-22"},"PeriodicalIF":0.0,"publicationDate":"2001-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63817069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sachiko Harada, Kumiko Kasashi, I. Wada, Konami Watanabe, M. Saeki, Y. Yamazaki, M. Ono, K. Tei, K. Ohmori, Masayo Kakinuma, H. Fukuda, Y. Totsuka
{"title":"Development of a Clinical pathway for Radiotherapy","authors":"Sachiko Harada, Kumiko Kasashi, I. Wada, Konami Watanabe, M. Saeki, Y. Yamazaki, M. Ono, K. Tei, K. Ohmori, Masayo Kakinuma, H. Fukuda, Y. Totsuka","doi":"10.11263/JSOTP1982.20.32","DOIUrl":"https://doi.org/10.11263/JSOTP1982.20.32","url":null,"abstract":"Radiotherapy is one of several treatments for oral cancer. To complete a one-month course of treatment, it is essential to manage radiation-induced complications effectively and help patients understand the treatment. To this end, clinical pathways can be useful. We have developed a pathway for patients receiving radiotherapy, which consists of such components as tests, treatments, consultations, teaching, medications, and assessment of patient progress. •g An Assessment Sheet•hand•gA List For Drug Selection•hwere also formatted as companion documents for the pathway, to record patient progress and to help physicians make effective drug choices. To evaluate the pathway, we implemented it for several patients. Two major improvements were observed : the patients came to understand more clearly the course of treatment in advance by using the pathway, and•gthe Assessment Sheet•hfacilitated follow-up by the multidisciplinary staff.","PeriodicalId":19590,"journal":{"name":"Oral Therapeutics and Pharmacology","volume":"20 1","pages":"32-38"},"PeriodicalIF":0.0,"publicationDate":"2001-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63817333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}